{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:26:09Z","timestamp":1792063569773,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA016086"],"award-info":[{"award-number":["P30CA016086"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007179","name":"University of New Mexico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007179","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008603","name":"Cancer Institute, University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008603","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006942","name":"Medical University of South Carolina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006942","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005567","name":"H. Lee Moffitt Cancer Center and Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005567","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007886","name":"Dana-Farber Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008457","name":"University of Virginia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008457","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005595","name":"University of California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007698","name":"University of Florida","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007698","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100025334","name":"St Joseph Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100025334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011566","name":"Sidney Kimmel Comprehensive Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011566","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007927","name":"University of Oklahoma Health Sciences Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007927","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005326","name":"Yale University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007322","name":"Fox Chase Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"National Cancer Institute Division of Cancer Prevention","doi-asserted-by":"publisher","award":["U10 CA180822"],"award-info":[{"award-number":["U10 CA180822"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"National Cancer Institute Division of Cancer Prevention","doi-asserted-by":"publisher","award":["U10CA181009"],"award-info":[{"award-number":["U10CA181009"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"National Cancer Institute Division of Cancer Prevention","doi-asserted-by":"publisher","award":["UG1CA233333"],"award-info":[{"award-number":["UG1CA233333"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"National Cancer Institute Division of Cancer Prevention","doi-asserted-by":"publisher","award":["R37CA226969"],"award-info":[{"award-number":["R37CA226969"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007810","name":"University of North Carolina Wilmington","doi-asserted-by":"publisher","award":["P30CA016086"],"award-info":[{"award-number":["P30CA016086"]}],"id":[{"id":"10.13039\/100007810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007234","name":"University of Chicago","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007234","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006808","name":"University of North Carolina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030930","name":"Hartford Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030930","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008102","name":"University of Cincinnati","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ygyno.2025.03.003","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T16:20:29Z","timestamp":1741450829000},"page":"66-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["A randomized phase II\/III study of paclitaxel\/carboplatin\/metformin versus paclitaxel\/carboplatin\/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology\/GOG study"],"prefix":"10.1016","volume":"195","author":[{"given":"Victoria L.","family":"Bae-Jump","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Sill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola A.","family":"Gehrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Merker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Corcoran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam D.","family":"Pfefferle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele C.","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan L.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea R.","family":"Hagemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Waggoner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roisin E.","family":"O'Cearbhaill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell I.","family":"Edelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"DiSilvestro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"McNally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee","family":"Fleury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramey D.","family":"Littell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick R.","family":"Ueland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather A.","family":"Lankes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Aghajanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ygyno.2025.03.003_bb0005","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/AOG.0000000000004676","article-title":"The changing landscape of gynecologic cancer mortality in the United States","volume":"139","author":"Giaquinto","year":"2022","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2025.03.003_bb0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2022.0009","article-title":"Racial and ethnic differences in hysterectomy-corrected uterine corpus cancer mortality by stage and histologic subtype","author":"Clarke","year":"2022","journal-title":"JAMA Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2025.03.003_bb0015","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","article-title":"Strelka2: fast and accurate calling of germline and somatic variants","volume":"15","author":"Kim","year":"2018","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.003_bb0020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ygyno.2014.01.032","article-title":"The complex triad of obesity, diabetes and race in type I and II endometrial cancers: prevalence and prognostic significance","volume":"133","author":"Ko","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2025.03.003_bb0025","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ajog.2011.05.042","article-title":"Understanding obesity and endometrial cancer risk: opportunities for prevention","volume":"205","author":"Schmandt","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"23","key":"10.1016\/j.ygyno.2025.03.003_bb0030","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa2302312","article-title":"Pembrolizumab plus chemotherapy in advanced endometrial cancer","volume":"388","author":"Eskander","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.ygyno.2025.03.003_bb0035","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1056\/NEJMoa2216334","article-title":"Dostarlimab for primary advanced or recurrent endometrial cancer","volume":"388","author":"Mirza","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"10333","key":"10.1016\/j.ygyno.2025.03.003_bb0040","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(22)00323-3","article-title":"Endometrial cancer","volume":"399","author":"Crosbie","year":"2022","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ygyno.2025.03.003_bb0045","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1158\/2159-8290.CD-12-0263","article-title":"Investigating metformin for cancer prevention and treatment: the end of the beginning","volume":"2","author":"Pollak","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ygyno.2025.03.003_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.942380","article-title":"Association between metformin use and the risk, prognosis of gynecologic cancer","volume":"12","author":"Yao","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.003_bb0055","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ygyno.2022.01.022","article-title":"Metformin and survival: is there benefit in a cohort limited to diabetic women with endometrial, breast, or ovarian cancer?","volume":"165","author":"Lemon","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"16","key":"10.1016\/j.ygyno.2025.03.003_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10163453","article-title":"Risk of endometrial cancer in women with diabetes: a population-based retrospective cohort study","volume":"10","author":"Zabuliene","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ygyno.2025.03.003_bb0065","article-title":"Jupiter microtubule-associated homolog 1 (JPT1): a predictive and pharmacodynamic biomarker of metformin response in endometrial cancers","author":"Bateman","year":"2019","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.003_bb0070","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ygyno.2009.09.024","article-title":"Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy","volume":"116","author":"Cantrell","year":"2010","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.03.003_bb0075","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ygyno.2012.01.009","article-title":"Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway","volume":"125","author":"Hanna","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.03.003_bb0080","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/cam4.353","article-title":"Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer","volume":"4","author":"Schuler","year":"2015","journal-title":"Cancer Med."},{"issue":"10","key":"10.1016\/j.ygyno.2025.03.003_bb0085","first-page":"2170","article-title":"Reversal of obesity-driven aggressiveness of endometrial cancer by metformin","volume":"9","author":"Guo","year":"2019","journal-title":"Am. J. Cancer Res."},{"issue":"4","key":"10.1016\/j.ygyno.2025.03.003_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061537","article-title":"Metformin downregulates the insulin\/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent manners","volume":"8","author":"Sarfstein","year":"2013","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.ygyno.2025.03.003_bb0095","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1447-0756.2011.01839.x","article-title":"Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expression","volume":"38","author":"Dong","year":"2012","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.ygyno.2025.03.003_bb0100","series-title":"Cation-Selective Transporters are Critical to the Anti-cancer Efficacy of Metformin in Endometrial Cancer. 44th Annual Meeting of the Society of Gynecologic Oncology, March 2013, Los Angeles, California","author":"Damery","year":"2013"},{"issue":"6","key":"10.1016\/j.ygyno.2025.03.003_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129280","article-title":"Combined targeted DNA sequencing in non-small cell lung cancer (NSCLC) using UNCseq and NGScopy, and RNA sequencing using UNCqeR for the detection of genetic aberrations in NSCLC","volume":"10","author":"Zhao","year":"2015","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.ygyno.2025.03.003_bb0110","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/cncy.21699","article-title":"FNA smears as a potential source of DNA for targeted next-generation sequencing of lung adenocarcinomas","volume":"124","author":"Treece","year":"2016","journal-title":"Cancer Cytopathol."},{"issue":"7","key":"10.1016\/j.ygyno.2025.03.003_bb0115","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/PAI.0000000000000215","article-title":"Identification of human papillomavirus infection in cancer tissue by targeted next-generation sequencing","volume":"24","author":"Montgomery","year":"2016","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"issue":"14","key":"10.1016\/j.ygyno.2025.03.003_bb0120","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"17","key":"10.1016\/j.ygyno.2025.03.003_bb0125","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1093\/bioinformatics\/btz033","article-title":"Improved indel detection in DNA and RNA via realignment with ABRA2","volume":"35","author":"Mose","year":"2019","journal-title":"Bioinformatics"},{"issue":"9","key":"10.1016\/j.ygyno.2025.03.003_bb0130","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res."},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.003_bb0135","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The Ensembl Variant Effect Predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol."},{"issue":"5","key":"10.1016\/j.ygyno.2025.03.003_bb0140","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.cell.2017.09.048","article-title":"Comprehensive analysis of hypermutation in human cancer","volume":"171","author":"Campbell","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.003_bb0145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.gpb.2020.02.001","article-title":"MSIsensor-pro: fast, accurate, and matched-normal-sample-free detection of microsatellite instability","volume":"18","author":"Jia","year":"2020","journal-title":"Genom. Proteom. Bioinf."},{"issue":"2","key":"10.1016\/j.ygyno.2025.03.003_bb0150","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.2015.190","article-title":"A clinically applicable molecular-based classification for endometrial cancers","volume":"113","author":"Talhouk","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"7447","key":"10.1016\/j.ygyno.2025.03.003_bb0155","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2025.03.003_bb0160","doi-asserted-by":"crossref","DOI":"10.1038\/s41416-023-02204-2","article-title":"Is it still worth pursuing the repurposing of metformin as a cancer therapeutic?","author":"Lord","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"20","key":"10.1016\/j.ygyno.2025.03.003_bb0165","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1001\/jama.2022.6147","article-title":"Effect of metformin vs placebo on invasive disease-free survival in patients with breast cancer: the MA.32 randomized clinical trial","volume":"327","author":"Goodwin","year":"2022","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ygyno.2025.03.003_bb0170","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s00125-012-2537-x","article-title":"A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts","volume":"55","author":"van Leeuwen","year":"2012","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.ygyno.2025.03.003_bb0175","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1158\/1055-9965.EPI-07-2686","article-title":"A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial Cancer","volume":"17","author":"Gunter","year":"2008","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"21","key":"10.1016\/j.ygyno.2025.03.003_bb0180","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1158\/1078-0432.CCR-06-0912","article-title":"Overexpression of the insulin-like growth factor I receptor and activation of the AKT pathway in hyperplastic endometrium","volume":"12","author":"McCampbell","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"35","key":"10.1016\/j.ygyno.2025.03.003_bb0185","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1200\/JCO.2016.69.4638","article-title":"Addressing the role of obesity in endometrial cancer risk, prevention, and treatment","volume":"34","author":"Onstad","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"17","key":"10.1016\/j.ygyno.2025.03.003_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176073","article-title":"Endometrial cancer as a metabolic disease with dysregulated pi3k signaling: shedding light on novel therapeutic strategies","volume":"21","author":"Kyo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ygyno.2025.03.003_bb0195","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fendo.2014.00076","article-title":"The IGF hormonal network in endometrial cancer: functions, regulation, and targeting approaches","volume":"5","author":"Bruchim","year":"2014","journal-title":"Front. Endocrinol."},{"issue":"6","key":"10.1016\/j.ygyno.2025.03.003_bb0200","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10552-016-0751-4","article-title":"Insulin\/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors","volume":"27","author":"Merritt","year":"2016","journal-title":"Cancer causes & control : CCC."},{"issue":"9","key":"10.1016\/j.ygyno.2025.03.003_bb0205","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1002\/cncr.22232","article-title":"Gynecologic oncology group s. racial disparity in survival among patients with advanced\/recurrent endometrial adenocarcinoma: a gynecologic oncology group study","volume":"107","author":"Maxwell","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2025.03.003_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1041535","article-title":"The present status of metformin in fertility-preserving treatment in atypical endometrial hyperplasia and endometrioid endometrial cancer","volume":"13","author":"Guan","year":"2022","journal-title":"Front. Endocrinol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825000721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825000721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T13:23:00Z","timestamp":1777641780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825825000721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":42,"alternative-id":["S0090825825000721"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.03.003","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized phase II\/III study of paclitaxel\/carboplatin\/metformin versus paclitaxel\/carboplatin\/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology\/GOG study","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}